What is Gilead Sciences's total revenue?

Gilead Sciences (GILD) reported total revenue of $6.96B in Q1 2026.

How has Gilead Sciences's total revenue changed year-over-year?

Gilead Sciences's total revenue increased by 4.4% year-over-year, from $6.67B to $6.96B.

What is the long-term trend for Gilead Sciences's total revenue?

Over 4 years (2021 to 2025), Gilead Sciences's total revenue has grown at a 1.9% compound annual growth rate (CAGR), from $27.31B to $29.44B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Gilead Sciences GILD Total Revenue

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

IncyteINCY

$1.27B+20.9%

ImmunityBio, Inc.IBRX

$44.21M+168%

PrecigenPGEN

$23.25M+1,634%

AnaptysBio, Inc.ANAB

$25.56M-8.0%

Sutro BiopharmaSTRO

$14.52M-16.5%

Segments

By product

See full

Biktarvy$3.36B+6.7%

Descovy$807M+37.7%

Trodelvy$402M+37.2%

Yescarta$332M-14.0%

Sofosbuvir/Velpatasvir$283M-18.2%

Genvoya$264M-27.5%

By geography

See full

Europe$1.14B+5.5%

Rest of World$889M-2.8%

Other financials

Income statement

See full

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$153.76B+13.9%

Enterprise value$168.3B+10.7%

P/E16.7×-5.9×

P/S5.2×+0.5×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's total revenue?: Gilead Sciences (GILD) reported total revenue of $6.96B in Q1 2026.
How has Gilead Sciences's total revenue changed year-over-year?: Gilead Sciences's total revenue increased by 4.4% year-over-year, from $6.67B to $6.96B.
What is the long-term trend for Gilead Sciences's total revenue?: Over 4 years (2021 to 2025), Gilead Sciences's total revenue has grown at a 1.9% compound annual growth rate (CAGR), from $27.31B to $29.44B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.